InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（24 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
24
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Yale Catriona, Chief Development Officer. Officer active across 1 company, notably Akero Therapeutics, Inc.. In total, 52 disclosures have been published. Split: 0 buy · 24 sells. Total volume traded: €3.4m. Activity tracked since 15 July 2021. The latest transaction was filed on 4 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Yale Catriona
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报52 总计
27,227 股Common StockSEC:0001193125-25-312100:0
47,573 股Common StockSEC:0001193125-25-312100:1
3,527 股@ US$28.351.4% 占其流量Common StockSEC:0001193125-25-268032:0
659 股@ US$43.020.4% 占其流量Common StockSEC:0000950170-25-114665:0
10,000 股@ US$19.872.9% 占其流量Common StockSEC:0000950170-25-097013:0
890 股@ US$23.8680.3% 占其流量Common StockSEC:0000950170-25-093322:0
1,633 股@ US$54.841.4% 占其流量Common StockSEC:0000950170-25-088636:0
10,000 股@ US$21.103.2% 占其流量Common StockSEC:0000950170-25-088207:0
2,803 股@ US$53.9962.4% 占其流量Common StockSEC:0000950170-25-085671:0
10,000 股@ US$21.103.1% 占其流量Common StockSEC:0000950170-25-074708:0
9,073 股@ US$21.102.7% 占其流量Common StockSEC:0000950170-25-054893:0
10,000 股@ US$21.103.1% 占其流量Common StockSEC:0000950170-25-041458:0
614 股@ US$44.880.4% 占其流量Common StockSEC:0000950170-25-039736:0
10,000 股@ US$21.103.3% 占其流量Common StockSEC:0000950170-25-024996:0
16,849 股@ US$0.6150.2% 占其流量Common StockSEC:0000950170-25-011445:0
49,074 股@ US$21.1016.0% 占其流量Common StockSEC:0000950170-25-011444:0
24,300 股0Common StockSEC:0000950170-24-138146:0
2,810 股@ US$30.791.3% 占其流量Common StockSEC:0000950170-24-136019:0
9,061 股@ US$21.102.9% 占其流量Common StockSEC:0000950170-24-128994:0
8,761 股@ US$27.6943.7% 占其流量Common StockSEC:0000950170-24-128994:1
300 股@ US$28.8230.1% 占其流量Common StockSEC:0000950170-24-128994:2
10,000 股@ US$0.6150.1% 占其流量Common StockSEC:0000950170-24-124230:0
4,515 股@ US$21.101.4% 占其流量Common StockSEC:0000950170-24-120231:0
14,825 股@ US$0.6150.1% 占其流量Common StockSEC:0000950170-24-115138:0
5,500 股@ US$0.6150.0% 占其流量Common StockSEC:0000950170-24-108837:0
52 条申报中的 25 条
About Yale Catriona
Yale Catriona is Chief Development Officer at Akero Therapeutics, Inc. She has 52 filings in total, and across the sampled recent filings, sells total 3418954 EUR between 2021-07-19 and 2025-12-09.
